CIPLA's weekly performance was lackluster, with a return of -1.07% and a Sharpe Ratio of -0.14, indicating poor risk-adjusted returns. The stock's volatility was relatively high at 28.53%, and it experienced a max drawdown of -2.55%. Compared to its peers, CIPLA outperformed SUNPHARMA and DIVISLAB but underperformed GRASIM. Overall, the stock was moderately risky this week.

[Volatility: 28.53%]